SRx Health Solutions, Inc. (SRXH): Nasdaq/NYSE listing notice — SRx Health receives NYSE American deficiency notice for stockholders' equity below $4M

SRx Health Solutions, Inc.

Received NYSE American notice on Oct 14, 2025 for non-compliance with Section 1003(a)(ii) due to stockholders' equity below $4M and net losses.
Company must submit compliance plan by Nov 13, 2025 and cure deficiency by July 14, 2026.
No immediate delisting; common stock continues trading on NYSE American under symbol SRXH.
Company is actively developing measures to regain compliance within the cure period.

Key facts

Extracted from this filing and checked against the source text.

Listing & Compliance Notices SEC 8-K Item 3.01 confidence 0.98

SRx Health Solutions, Inc. received a nyse_american deficiency notice notice regarding stockholders equity (rules 1003(a)(ii), 1009).

Exchange: nyse american
Notice: deficiency notice
Deficiency: stockholders equity
Rules: 1003(a)(ii), 1009

Exact text from the filing

October 14, 2025, SRx Health Solutions, Inc, a Delaware corporation. (the “Company”) received a written notice (the “Notice”) from the NYSE American LLC (the “NYSE American”) indicating that the Company is not in compliance with the NYSE American continued listing standard set forth in Section 1003(a)(ii) of the NYSE American Company Guide (“Section 1003(a)(ii)”). Section 1003(a)(ii) requires a listed company to have stockholders’ equity of $4 million or more if the listed company has reported losses from continuing operations and/or net losses in three of its four most recent fiscal years.. T

View on SEC.gov

Listing & Compliance Notices SEC 8-K Item 3.01 confidence 0.95

SRx Health Solutions, Inc. received a nyse_american deficiency notice notice regarding stockholders equity (rules 1003(a)(ii)).

Exchange: nyse american
Notice: deficiency notice
Deficiency: stockholders equity
Rules: 1003(a)(ii)

Exact text from the filing

October 14, 2025, SRx Health Solutions, Inc, a Delaware corporation. (the “Company”) received a written notice (the “Notice”) from the NYSE American LLC (the “NYSE American”) indicating that the Company is not in compliance with the NYSE American continued listing standard set forth in Section 1003(a)(ii) of the NYSE American Company Guide (“Section 1003(a)(ii)”). Section 1003(a)(ii) requires a listed company to have stockholders’ equity of $4 million or more if the listed company has reported losses from continuing operations and/or net losses in three of its four most recent fiscal years.. T

View on SEC.gov

20 listing & compliance notices filed in the last 30 days. Browse all listing & compliance notices →

SRx Health Solutions, Inc. filing history →

Source: SEC EDGAR

accession 0001493152-25-018441

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.